Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_provenance.
- NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_assertion description "[A truncating allele of the cell cycle checkpoint kinase CHK2 is present in 1% of the population, conferring a moderate increase in breast cancer risk, and inactivation of chk2 enhances mammary tumorigenesis in mice with targeted inactivation of brca1.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_provenance.
- NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_assertion evidence source_evidence_literature NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_provenance.
- NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_assertion SIO_000772 16488990 NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_provenance.
- NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_assertion wasDerivedFrom befree-2016 NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_provenance.
- NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_assertion wasGeneratedBy ECO_0000203 NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_provenance.
- befree-2016 importedOn "2016-02-19" NP536500.RA0if7rRbN9Eiw8ddFDCw95PoNBM6TBr8r0FokHVC4iG0130_provenance.